Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 11, 2008

View Archived Issues

CytRx unveils strategy for clinical development of pipeline assets

Solbec changes name to Freedom Eye

Novel analgesic agents reported in recent patent literature

New therapeutic agents for AD and other neurological disorders reported in recent patents

Genentech initiates phase II hedgehog pathway inhibitor trial in ovarian cancer

CHMP recommends approval of Schering-Plough's Temodal for certain primary brain tumors

AstraZeneca and Bristol-Myers expand dapagliflozin collaboration to include Japan

Genentech licenses ImmunoGen's TAP technology to develop anticancer therapeutics

4SC completes dosing and reports interim results from phase I clinical trial of 4SC-201

FDA issues complete response letter denying approval to Targanta's NDA for oritavancin

Adult lymphoma research group chooses Revlimid for phase III study

Affymetrix completes acquisition of assay company, Panomics

Cancer vaccine HSPPC-96 invokes responses in phase I glioma trial

Ozarelix's effects on histamine release assessed, administration routes compared

Adeno-associated virus liver-directed gene therapy effective in hyperbilirubinemia model

Kiadis Pharma receives two FDA orphan drug designations for Reviroc

MAA for Medivir's Lipsovir validated by American and European regulatory authorities

Clinical evaluation of BIW-8962 encouraged by activity in preclinical myeloma models

Sosei reports positive results from two phase I trials of SD-118 for neuropathic pain

Haemacure reports results from preclinical study of fibrin sealant Hemaseel HMN

FDA approves Quintessence's IND to initiate phase I trial of QBI-139 in solid tumors

Pfizer and Sigma-Tau sign license agreement for ACT malaria drug Eurartesim in Africa

HGS reports results from phase III clinical trial of Albuferon in patients with chronic hepatitis C

New treatment options for genitourinary disorders reported in recent Japanese patents

Studies with AVL-101 highlight Bruton's tyrosine kinase as a target in B-cell lymphoma

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...